Seth Howard Berk, MD, a hematologist and medical oncologist with RCCA, reveals four facts that he shares with his patients when they ask about clinical trials. First, a drug has been thoroughly tested well before it reaches the clinical trial stage. Pre-clinical trial testing involves looking at a drug’s effects on animals as well as … Continued
A recent article on nj.com, titled “Prostate cancer: Answers to three key questions about trends in New Jersey, recent advances,” reveals the truth about three common prostate cancer myths. According to experts at the American Cancer Society, National Cancer Institute, and Food and Drug Administration, the majority of men diagnosed with prostate cancer do not … Continued
A recent article on nj.com, titled “Bladder cancer trends in Montgomery and Prince George’s counties: Welcome news – and 3 facts you need to know” highlights the expertise of RCCA’s own Dr. Ralph V. Boccia. According to the board-certified hematologist and medical oncologist, there are three main facts to keep in mind about bladder cancer. … Continued
Dr. Seth Howard Berk, a board-certified hematologist and medical oncologist who practices in Mount Holly, NJ with Regional Cancer Care Associates (RCCA), discusses new developments in oncology treatments for skin disorders. Dr. Berk mentions that many of the new tools used in combating skin cancers focus on harnessing the power of the immune system, and … Continued
Addressing the value changes that CMS is mandating takes enormous planning and study. Many oncology practices are grappling with the new programs that the government payer has asked them to adopt.
Terrill Jordan is President and CEO of Regional Cancer Care Associates (RCCA). He spoke to Symptoms & Cures about RCCA’s move toward value-based care in the field of cancer treatment.
The Centers for Medicare & Medicaid Services (CMS) has announced that it has selected Regional Cancer Care Associates LLC (RCCA) as one of nearly 200 physician group practices and 17 health insurance companies to participate in a care delivery model that supports and encourages higher quality, more coordinated cancer care. The Medicare arm of the Oncology Care Model includes more than 3,200 oncologists and will cover approximately 155,000 Medicare beneficiaries nationwide.
Regional Cancer Care Associates LLC (RCCA) and Osler Health have partnered up to deliver higher-quality and higher-efficiency integrated cancer care to New Jersey. RCCA is New Jersey’s largest cancer care physician’s group, and Osler Health is one of New Jersey’s largest next-generation patient-centered physician networks. Together, these groups of physicians will hold hospitals accountable to … Continued
Prnewswire.com HACKENSACK, N.J., Feb. 1, 2016 /PRNewswire-USNewswire/ — Regional Cancer Care Associates LLC (RCCA) is working with United Healthcare to advance a cancer care payment initiative that rewards physicians for focusing on best treatment practices, quality patient care and better health outcomes. The program pays participating medical oncologists more if they demonstrate superior clinical results … Continued
Please join us in congratulating our RCCA researchers from the Hackensack Division on the presentation of leading-edge clinical data in blood cancers at the ASH Meeting in Orlando, FL. The press release can be found at the below link.